| 18 years and more
- | Country :
- France
- | organs :
- Prostate
- | Specialty :
- Chimiothérapie
- Thérapies Ciblées
Extract
A randomized double-blind phase III trial comparing docetaxel combined with dasatinib to docetaxel combined with placebo in castration-resistant prostate cancer.
Scientific Abstract
en cours d'intégration;